Natixis Advisors LLC boosted its stake in Barclays PLC (NYSE:BCS) by 286.1% during the third quarter, HoldingsChannel reports. The firm owned 3,565,033 shares of the financial services provider’s stock after buying an additional 2,641,608 shares during the period. Natixis Advisors LLC’s holdings in Barclays were worth $43,315,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Sage Mountain Advisors LLC raised its stake in Barclays by 7.7% in the second quarter. Sage Mountain Advisors LLC now owns 11,767 shares of the financial services provider’s stock valued at $126,000 after purchasing an additional 838 shares in the last quarter. Apollon Wealth Management LLC raised its stake in shares of Barclays by 10.0% during the third quarter. Apollon Wealth Management LLC now owns 11,826 shares of the financial services provider’s stock worth $144,000 after acquiring an additional 1,075 shares in the last quarter. Hexagon Capital Partners LLC raised its stake in shares of Barclays by 32.4% during the third quarter. Hexagon Capital Partners LLC now owns 4,624 shares of the financial services provider’s stock worth $56,000 after acquiring an additional 1,132 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd raised its stake in shares of Barclays by 6.9% during the third quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 17,565 shares of the financial services provider’s stock worth $213,000 after acquiring an additional 1,137 shares in the last quarter. Finally, AMG National Trust Bank raised its stake in shares of Barclays by 0.4% during the second quarter. AMG National Trust Bank now owns 333,744 shares of the financial services provider’s stock worth $3,574,000 after acquiring an additional 1,343 shares in the last quarter. 3.39% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
BCS has been the topic of several research reports. StockNews.com raised shares of Barclays from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Kepler Capital Markets initiated coverage on shares of Barclays in a research note on Thursday, September 5th. They set a “buy” rating on the stock. Finally, The Goldman Sachs Group initiated coverage on shares of Barclays in a research note on Tuesday, October 8th. They set a “buy” rating on the stock.
Barclays Price Performance
Shares of NYSE:BCS opened at $13.21 on Monday. Barclays PLC has a fifty-two week low of $6.91 and a fifty-two week high of $13.57. The business has a 50-day simple moving average of $12.41 and a two-hundred day simple moving average of $11.67. The company has a debt-to-equity ratio of 5.67, a quick ratio of 1.35 and a current ratio of 1.35. The firm has a market cap of $47.84 billion, a price-to-earnings ratio of 8.99 and a beta of 1.41.
Barclays (NYSE:BCS – Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The financial services provider reported $0.56 EPS for the quarter. Barclays had a net margin of 17.83% and a return on equity of 6.30%. The firm had revenue of $8.52 billion during the quarter. During the same period in the previous year, the company earned $0.42 EPS. On average, analysts expect that Barclays PLC will post 1.71 earnings per share for the current year.
About Barclays
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International division segments. It offers financial services, such as retail banking, credit cards, wholesale banking, investment banking, wealth management, and investment management services.
Featured Articles
- Five stocks we like better than Barclays
- Profitably Trade Stocks at 52-Week Highs
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Short Selling: How to Short a Stock
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding BCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Barclays PLC (NYSE:BCS – Free Report).
Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with MarketBeat.com's FREE daily email newsletter.